Page last updated: 2024-10-17

aminocaproic acid and Aqueductal Stenosis

aminocaproic acid has been researched along with Aqueductal Stenosis in 9 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research Excerpts

ExcerptRelevanceReference
"5 g of epsilon-aminocaproic acid (EACA) per hour after subarachnoid hemorrhage (SAH) from an intracranial aneurysm."7.67Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. ( Bakay, RA; Burchiel, KJ; Hoffman, JM, 1984)
"Long-term administration of the antifibrinolytic agent epsilon aminocaproic acid (EACA) reduces the rate of rehemorrhage in patients with aneurysmal subarachnoid hemorrhage (SAH), but is associated with cerebral ischemia."3.76Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. ( Ardelt, AA; Fisher, WS; Harrigan, MR; Rajneesh, KF, 2010)
"5 g of epsilon-aminocaproic acid (EACA) per hour after subarachnoid hemorrhage (SAH) from an intracranial aneurysm."3.67Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition. ( Bakay, RA; Burchiel, KJ; Hoffman, JM, 1984)
"The incidence and severity of cerebral vasospasm and hydrocephalus following induced subarachnoid hemorrhage in an experimental group of animals that subsequently received epsilon-aminocaproic acid was compared to that seen in a control group that received no antifibrinolytic therapy."3.67An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus. ( Dujovny, M; Heros, RC; Kenning, JA; Latchaw, RE; Nelson, D, 1984)
"The incidence of hydrocephalus or symptomatic vasospasm was not unduly elevated in patients receiving preoperative EACA."1.30Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. ( Horner, TG; Leipzig, TJ; Redelman, K, 1997)
"An increased incidence of communicating hydrocephalus following subarachnoid hemorrhage has been observed on the neurosurgical service at Vanderbilt University Hospital during the past four years."1.26Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor. ( Park, BE, 1979)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harrigan, MR1
Rajneesh, KF1
Ardelt, AA1
Fisher, WS1
Nina, P1
Schisano, G1
Thomas, G1
Evelyne, E1
Burchiel, KJ1
Hoffman, JM1
Bakay, RA1
Kenning, JA1
Heros, RC1
Dujovny, M1
Latchaw, RE1
Nelson, D1
Leipzig, TJ1
Redelman, K1
Horner, TG1
Park, BE1
Peerless, SJ1
Langtitt, TW1

Other Studies

9 other studies available for aminocaproic acid and Aqueductal Stenosis

ArticleYear
Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus.
    Neurosurgery, 2010, Volume: 67, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Antifibrinolytic Agents; Brain Ischem

2010
Antifibrinolytic drugs in subarachnoid hemorrhage by ruptured aneurysms.
    Neurosurgery, 2011, Volume: 68, Issue:6

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Brain Ischemia; Female; Humans; Hydrocephalus; Male; Sub

2011
Antifibrinolytic in subarachnoid hemorrhage.
    Neurosurgery, 2011, Volume: 69, Issue:2

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Brain Ischemia; Female; Humans; Hydrocephalus; Male; Sub

2011
Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Neurosurgery, 1984, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Aminocaproates; Aminocaproic Acid; Cerebral Arteries; Depression, Chemical;

1984
An experimental study of the influence of antifibrinolytic therapy on post-subarachnoid-hemorrhagic cerebral vasospasm and hydrocephalus.
    Surgical neurology, 1984, Volume: 21, Issue:2

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Cerebral Angiography; Cerebral Hemorrhage; Hydrocephalus

1984
Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Journal of neurosurgery, 1997, Volume: 86, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aminocaproic Acid; Aneurysm, Ruptured; Antifibrinolytic Agents; Huma

1997
Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilon amino caproic acid as a possible predisposing factor.
    Surgical neurology, 1979, Volume: 11, Issue:1

    Topics: Adult; Aged; Aminocaproates; Aminocaproic Acid; Angiography; Animals; Cerebral Ventricles; Dogs; Fem

1979
Pre- and postoperative management of cerebral aneurysms.
    Clinical neurosurgery, 1979, Volume: 26

    Topics: Aminocaproic Acid; Brain Edema; Humans; Hydrocephalus; Hypertension; Intracranial Aneurysm; Ischemic

1979
Conservative care of intracranial hemorrhage.
    Advances in neurology, 1977, Volume: 16

    Topics: Aminocaproic Acid; Blood Pressure; Brain Edema; Cerebral Hemorrhage; Humans; Hydrocephalus; Hyperton

1977